180 related articles for article (PubMed ID: 2551774)
1. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
[TBL] [Abstract][Full Text] [Related]
2. Expression of env sequences of the bovine leukemia virus (BLV) in the yeast Saccharomyces cerevisiae.
Brantl S; Eldarov MA; Rössler H; Drescher B; Lang H; Rosenthal S; Skryabin KG
Yeast; 1988 Mar; 4(1):47-59. PubMed ID: 2849260
[TBL] [Abstract][Full Text] [Related]
3. High yield synthesis of the bovine leukemia virus (BLV) p24 major internal protein in Saccharomyces cerevisiae.
Dumont J; Legrain M; Portetelle D; Brasseur R; Burny A; Hilger F
Gene; 1989 Jul; 79(2):219-26. PubMed ID: 2551773
[TBL] [Abstract][Full Text] [Related]
4. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
Portetelle D; Couez D; Bruck C; Kettmann R; Mammerickx M; Van der Maaten M; Brasseur R; Burny A
Virology; 1989 Mar; 169(1):27-33. PubMed ID: 2466370
[TBL] [Abstract][Full Text] [Related]
5. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
De Giuseppe A; Feliziani F; Rutili D; De Mia GM
Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
[TBL] [Abstract][Full Text] [Related]
6. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.
Bruck C; Rensonnet N; Portetelle D; Cleuter Y; Mammerickx M; Burny A; Mamoun R; Guillemain B; van der Maaten MJ; Ghysdael J
Virology; 1984 Jul; 136(1):20-31. PubMed ID: 6204449
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
8. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
10. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of bovine leukemia virus antigens in Escherichia coli.
Ulrich R; Siakkou H; Platzer C; Bossmann H; Möhring R; Wiedmann M; Bähring S; Rosenthal S
Arch Exp Veterinarmed; 1990; 44(6):909-16. PubMed ID: 1966363
[TBL] [Abstract][Full Text] [Related]
12. Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).
Lim SI; Jeong W; Tark DS; Yang DK; Kweon CH
J Vet Sci; 2009 Dec; 10(4):331-6. PubMed ID: 19934599
[TBL] [Abstract][Full Text] [Related]
13. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
14. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of subregions of recombinant bovine leukemia virus (BLV) glycoprotein gp51 for antibody detection.
Bai L; Soya M; Ichikawa M; Matsuura R; Arimura Y; Wada S; Aida Y
J Virol Methods; 2023 Jan; 311():114644. PubMed ID: 36332713
[TBL] [Abstract][Full Text] [Related]
16. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
17. Bovine leukemia virus-gp51 antigen expression is associated with CD5 and IgM markers on infected lymphocytes.
Meirom R; Moss S; Brenner J
Vet Immunol Immunopathol; 1997 Oct; 59(1-2):113-9. PubMed ID: 9437829
[TBL] [Abstract][Full Text] [Related]
18. Immunological characterization of BLV proteins synthesized in Escherichia coli.
Siakkou H; Ulrich R; Uelze A; Möhring R; Rosenthal S
Acta Virol; 1990 May; 34(3):256-62. PubMed ID: 1703391
[TBL] [Abstract][Full Text] [Related]
19. In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety.
Portetelle D; Bruck C; Mammerickx M; Burny A
Virology; 1980 Aug; 105(1):223-33. PubMed ID: 6158161
[No Abstract] [Full Text] [Related]
20. Production of monoclonal antibody to bovine leukemia virus glycoprotein gp51 by in vitro immunization.
Sasaki O; Tanaka M; Okabe T; Imanishi J
Microbiol Immunol; 1990; 34(4):401-5. PubMed ID: 2163485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
